adenoviral vector vaccine
Showing 1 - 25 of 8,839
HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )
Withdrawn
- HIV Infections
- VRC-HIVDNA016-00-VP
- +3 more
- (no location specified)
Oct 28, 2021
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
Norovirus Infections Trial in Cypress (VXA-G1.1-NN)
Completed
- Norovirus Infections
- VXA-G1.1-NN
-
Cypress, CaliforniaAltaSciences LA
Apr 27, 2022
Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)
Completed
- Norovirus Infections
- VXA-GI.1.NN
- Placebo Tablet
-
Cypress, California
- +2 more
Sep 19, 2022
HIV Trial in United States (DNA plasmid vaccine, Recombinant adenoviral serotype 5 (rAD5) vector vaccine, DNA vaccine )
Terminated
- HIV Infections
- DNA plasmid vaccine
- +3 more
-
Birmingham, Alabama
- +21 more
Oct 13, 2021
Norovirus Infections Trial in Cypress (VXA-G1.1-NN)
Completed
- Norovirus Infections
- VXA-G1.1-NN
-
Cypress, CaliforniaWCCT Global, Inc.
Sep 19, 2022
Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)
Not yet recruiting
- Ebola Sudan Virus Disease
- cAD3-Sudan Ebolavirus Vaccine
- Placebo
-
Siaya, Kenya
- +1 more
Sep 7, 2023
Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)
Not yet recruiting
- Marburg Virus Disease
- cAd3-Marburg vaccine
- Placebo
-
Siaya, Kenya
- +1 more
Apr 17, 2023
HIV Trial in United States (VRC-HIVADV014-00-VP)
Completed
- HIV Infections
- VRC-HIVADV014-00-VP
-
Baltimore, Maryland
- +7 more
Oct 13, 2021
SARS-CoV-2, Covid19 Trial in Brussels (Serological testing)
Recruiting
- SARS-CoV-2
- Covid19
- Serological testing
-
Brussels, BelgiumUZ Brussel
May 17, 2022
Norovirus Infection Trial in Cleveland (VXA-G1.1-NN, VXA-G2.4-NS, Placebo Tablets)
Completed
- Norovirus Infection
- VXA-G1.1-NN
- +2 more
-
Cleveland, OhioRapid Medical Research
Apr 23, 2021
HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)
Completed
- HIV Infections
- DNA Vaccine
- +5 more
-
Birmingham, Alabama
- +9 more
Oct 13, 2021
COVID-19 Trial (GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition)
Not yet recruiting
- COVID-19
- GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition
- (no location specified)
Oct 4, 2023
COVID-19 Trial (GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile))
Not yet recruiting
- COVID-19
- GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile)
- (no location specified)
Oct 4, 2023
Breast Cancer Trial in Los Angeles (Ad-sig-hMUC-1/ecdCD40L vaccine)
Withdrawn
- Breast Cancer
- Ad-sig-hMUC-1/ecdCD40L vaccine
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020
Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)
Recruiting
- Metastatic Cancer
- Epithelial Tumor
- NG-641
-
Los Angeles, California
- +5 more
Jan 16, 2023
Epidemic Meningitis Trial (MCV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- (no location specified)
Jul 5, 2023
COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))
Completed
- COVID-19
- hAd5-S-Fusion+N-ETSD
- Placebo (0.9% (w/v) saline)
-
Newport Beach, CaliforniaHoag Memorial Hospital Presbyterian
Sep 1, 2023
Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)
Completed
- Breast Neoplasms
- +3 more
- Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022
COVID-19 Trial in Singapore (Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation)
Not yet recruiting
- COVID-19
- Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
-
Singapore, SingaporeNational University Hospital
Jan 29, 2023
Epidemic Meningitis Trial (MCV4, MSPV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- MSPV4
- (no location specified)
Aug 21, 2023
COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus
Completed
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
-
Taizhou, Jiangsu, ChinaTaixing City center for Disease Control and Prevention
Oct 28, 2022
HIV Trial run by the NIAID (VRC-HIVADV014-00-VP)
Completed
- HIV Infections
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial (Gam-COVID-Vac, Placebo)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Acute Respiratory Disease
- Gam-COVID-Vac
- Placebo
- (no location specified)
Mar 7, 2022